Boya Bio-Pharmaceutical Group (300294)

Boya Bio-Pharmaceutical Group (300294)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021


Boya Bio-pharmaceutical Group Co., Ltd., formerly Jiangxi Boya Bio-pharmaceutical Co., Ltd, is a China-based company principally engaged in the research, development, production and distribution of blood products. The Company’s main products include human albumin, freeze-drying intravenous injection human immune globulin, human immune globulin, hepatitis B human immune globulin, hydrophobia human immune globulin, human fibrinogen, metformin hydrochloride, calcium dobesilate capsules, glimepiride and pioglitazone hydrochloride dispersible tablets, among others. The Company’s blood products are mainly used in the treatment of tumor, liver diseases and diabetes, among others. The Company also provides diabetic pharmaceuticals and biochemical pharmaceuticals. The Company distributes its products mainly in domestic market.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner